<b><i><font color="#f44336">Neo adjuvant</font></i></b>
I: TAC, AT, TP
II: AC-T, clinical trials: T+PD-(L)1
<b><i><font color="#f44336">adjuvant</font></i></b>
<b>lymph nodes+<br>/T>2cm</b>
I: AC-T, ddAC-ddT
II: TAC, FEC-T,chemo-capecitabine
III: FAC*6
<b>lymph nodes- <br>and T≤2cm</b>
I: AC, TC
II: AC-T
<b><i><font color="#f44336">mTNBC</font></i></b>
<b>failed to A treatment</b>
I: T single: nab-paclitaxel, docetaxel，paclitaxel<br>combo: TX, GP, GT, TP
II: single: X, N, G, Etoposide<br>combo: nab-paclitaxel +PD-(L)1;T+Beva
III: paclitaxel liposomes, Olaparib, Doxorubicin liposomes, chemo+PD-1
<b>failed to A and T treatment</b>
I: single: X, N, G<br>combo: NP, GP, NX
II: single: Eribulin, nab-paclitaxel, Etoposide<br>combo: Utidelone+X, X+beva, nab-paclitaxel+chemo
III: paclitaxel liposomes, Doxorubicin liposomes,
